{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:09:02Z","timestamp":1789229342521,"version":"build-2803163510"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Samuel and Emma Winters Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10875-024-01681-1","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T11:18:48Z","timestamp":1709810328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["The Complexity of Being A20: From Biological Functions to Genetic Associations"],"prefix":"10.1007","volume":"44","author":[{"given":"Urekha","family":"Karri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Harasimowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Carpio Tumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"1681_CR1","doi-asserted-by":"publisher","first-page":"12424","DOI":"10.1016\/S0021-9258(18)42292-2","volume":"267","author":"AW Opipari Jr","year":"1992","unstructured":"Opipari AW Jr, Hu HM, Yabkowitz R, Dixit VM. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem. 1992;267:12424\u20137.","journal-title":"J Biol Chem"},{"key":"1681_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nri3313","volume":"12","author":"A Ma","year":"2012","unstructured":"Ma A, Malynn BA. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol. 2012;12:774\u201385. https:\/\/doi.org\/10.1038\/nri3313.","journal-title":"Nat Rev Immunol"},{"key":"1681_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnmol.2015.00021","volume":"8","author":"A Abbasi","year":"2015","unstructured":"Abbasi A, Forsberg K, Bischof F. The role of the ubiquitin-editing enzyme A20 in diseases of the central nervous system and other pathological processes. Front Mol Neurosci. 2015;8:21. https:\/\/doi.org\/10.3389\/fnmol.2015.00021.","journal-title":"Front Mol Neurosci"},{"key":"1681_CR4","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/ng.202","volume":"40","author":"SL Musone","year":"2008","unstructured":"Musone SL, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet. 2008;40:1062\u20134. https:\/\/doi.org\/10.1038\/ng.202.","journal-title":"Nat Genet"},{"key":"1681_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/ng.200","volume":"40","author":"RR Graham","year":"2008","unstructured":"Graham RR, et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet. 2008;40:1059\u201361. https:\/\/doi.org\/10.1038\/ng.200.","journal-title":"Nat Genet"},{"key":"1681_CR6","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/ar2650","volume":"11","author":"R Dieguez-Gonzalez","year":"2009","unstructured":"Dieguez-Gonzalez R, et al. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Res Ther. 2009;11:R42. https:\/\/doi.org\/10.1186\/ar2650.","journal-title":"Arthritis Res Ther"},{"key":"1681_CR7","first-page":"708","volume":"28","author":"LM Elsby","year":"2010","unstructured":"Elsby LM, et al. Functional evaluation of TNFAIP3 (A20) in rheumatoid arthritis. Clin Exp Rheumatol. 2010;28:708\u201314.","journal-title":"Clin Exp Rheumatol"},{"key":"1681_CR8","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/ard.2009.127928","volume":"69","author":"P Dieud\u00e9","year":"2010","unstructured":"Dieud\u00e9 P, et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis. 2010;69:1958\u201364. https:\/\/doi.org\/10.1136\/ard.2009.127928.","journal-title":"Ann Rheum Dis"},{"key":"1681_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","volume":"48","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48:67\u201373. https:\/\/doi.org\/10.1038\/ng.3459.","journal-title":"Nat Genet"},{"key":"1681_CR10","doi-asserted-by":"publisher","first-page":"845262","DOI":"10.3389\/fphar.2022.845262","volume":"13","author":"W Bai","year":"2022","unstructured":"Bai W, Huo S, Li J, Shao J. Advances in the study of the ubiquitin-editing enzyme A20. Front Pharmacol. 2022;13:845262. https:\/\/doi.org\/10.3389\/fphar.2022.845262.","journal-title":"Front Pharmacol"},{"key":"1681_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"IE Wertz","year":"2004","unstructured":"Wertz IE, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430:694\u20139. https:\/\/doi.org\/10.1038\/nature02794.","journal-title":"Nature"},{"key":"1681_CR12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.immuni.2013.03.008","volume":"38","author":"TT Lu","year":"2013","unstructured":"Lu TT, et al. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. Immunity. 2013;38:896\u2013905. https:\/\/doi.org\/10.1016\/j.immuni.2013.03.008.","journal-title":"Immunity"},{"key":"1681_CR13","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/s41590-019-0492-0","volume":"20","author":"NW Zammit","year":"2019","unstructured":"Zammit NW, et al. Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity. Nat Immunol. 2019;20:1299\u2013310. https:\/\/doi.org\/10.1038\/s41590-019-0492-0.","journal-title":"Nat Immunol"},{"key":"1681_CR14","doi-asserted-by":"publisher","unstructured":"El Khouri E. et al. A critical region of A20 unveiled by missense TNFAIP3 variations that lead to autoinflammation. Elife. 2023;12. https:\/\/doi.org\/10.7554\/eLife.81280.","DOI":"10.7554\/eLife.81280"},{"key":"1681_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/cmi.2011.59","volume":"9","author":"N Shembade","year":"2012","unstructured":"Shembade N, Harhaj EW. Regulation of NF-kappaB signaling by the A20 deubiquitinase. Cell Mol Immunol. 2012;9:123\u201330. https:\/\/doi.org\/10.1038\/cmi.2011.59.","journal-title":"Cell Mol Immunol"},{"key":"1681_CR16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/ncomms2567","volume":"4","author":"Y Kulathu","year":"2013","unstructured":"Kulathu Y, et al. Regulation of A20 and other OTU deubiquitinases by reversible oxidation. Nat Commun. 2013;4:1569. https:\/\/doi.org\/10.1038\/ncomms2567.","journal-title":"Nat Commun"},{"key":"1681_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41590-020-0621-9","volume":"21","author":"A Martens","year":"2020","unstructured":"Martens A, et al. Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities. Nat Immunol. 2020;21:381\u20137. https:\/\/doi.org\/10.1038\/s41590-020-0621-9.","journal-title":"Nat Immunol"},{"key":"1681_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.molcel.2010.10.009","volume":"40","author":"I Bosanac","year":"2010","unstructured":"Bosanac I, et al. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling. Mol Cell. 2010;40:548\u201357. https:\/\/doi.org\/10.1016\/j.molcel.2010.10.009.","journal-title":"Mol Cell"},{"key":"1681_CR19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature16165","volume":"528","author":"IE Wertz","year":"2015","unstructured":"Wertz IE, et al. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature. 2015;528:370\u20135. https:\/\/doi.org\/10.1038\/nature16165.","journal-title":"Nature"},{"key":"1681_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ni1563","volume":"9","author":"N Shembade","year":"2008","unstructured":"Shembade N, et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat Immunol. 2008;9:254\u201362. https:\/\/doi.org\/10.1038\/ni1563.","journal-title":"Nat Immunol"},{"key":"1681_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/emboj.2008.285","volume":"28","author":"N Shembade","year":"2009","unstructured":"Shembade N, Parvatiyar K, Harhaj NS, Harhaj EW. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling. EMBO J. 2009;28:513\u201322. https:\/\/doi.org\/10.1038\/emboj.2008.285.","journal-title":"EMBO J"},{"key":"1681_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41590-020-0634-4","volume":"21","author":"B Razani","year":"2020","unstructured":"Razani B, et al. Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation. Nat Immunol. 2020;21:422\u201333. https:\/\/doi.org\/10.1038\/s41590-020-0634-4.","journal-title":"Nat Immunol"},{"key":"1681_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bbamcr.2008.09.013","volume":"1793","author":"L Li","year":"2009","unstructured":"Li L, Soetandyo N, Wang Q, Ye Y. The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation. Biochim Biophys Acta. 2009;1793:346\u201353. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.09.013.","journal-title":"Biochim Biophys Acta"},{"key":"1681_CR24","doi-asserted-by":"publisher","first-page":"7718","DOI":"10.4049\/jimmunol.0803313","volume":"182","author":"M D\u00fcwel","year":"2009","unstructured":"D\u00fcwel M, et al. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J Immunol. 2009;182:7718\u201328. https:\/\/doi.org\/10.4049\/jimmunol.0803313.","journal-title":"J Immunol"},{"key":"1681_CR25","doi-asserted-by":"publisher","first-page":"585880","DOI":"10.3389\/fimmu.2020.585880","volume":"11","author":"P Gough","year":"2020","unstructured":"Gough P, Myles IA. Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects. Front Immunol. 2020;11:585880. https:\/\/doi.org\/10.3389\/fimmu.2020.585880.","journal-title":"Front Immunol"},{"key":"1681_CR26","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41419-019-1937-y","volume":"10","author":"D Priem","year":"2019","unstructured":"Priem D, et al. A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms. Cell Death Dis. 2019;10:692. https:\/\/doi.org\/10.1038\/s41419-019-1937-y.","journal-title":"Cell Death Dis"},{"key":"1681_CR27","doi-asserted-by":"publisher","unstructured":"Song HY, Rothe M, Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1\/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci U S A. 1996;93:6721-6725.https:\/\/doi.org\/10.1073\/pnas.93.13.6721.","DOI":"10.1073\/pnas.93.13.6721"},{"key":"1681_CR28","doi-asserted-by":"publisher","first-page":"100811","DOI":"10.1016\/j.jbc.2021.100811","volume":"297","author":"Z Meng","year":"2021","unstructured":"Meng Z, et al. A20\/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48- and K63-linked polyubiquitination of effectors MyD88 and TBK1. J Biol Chem. 2021;297:100811. https:\/\/doi.org\/10.1016\/j.jbc.2021.100811.","journal-title":"J Biol Chem"},{"key":"1681_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/annrheumdis-2016-209454","volume":"76","author":"K De Wilde","year":"2017","unstructured":"De Wilde K, et al. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis. Ann Rheum Dis. 2017;76:585\u201392. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209454.","journal-title":"Ann Rheum Dis"},{"key":"1681_CR30","doi-asserted-by":"publisher","first-page":"30912","DOI":"10.1074\/jbc.M114.591966","volume":"289","author":"HP Moll","year":"2014","unstructured":"Moll HP, et al. A20 regulates atherogenic interferon (IFN)-\u03b3 signaling in vascular cells by modulating basal IFN\u03b2 levels. J Biol Chem. 2014;289:30912\u201324. https:\/\/doi.org\/10.1074\/jbc.M114.591966.","journal-title":"J Biol Chem"},{"key":"1681_CR31","doi-asserted-by":"publisher","first-page":"1122586","DOI":"10.3389\/fimmu.2023.1122586","volume":"14","author":"CLC Almeida-da-Silva","year":"2023","unstructured":"Almeida-da-Silva CLC, Savio LEB, Coutinho-Silva R, Ojcius DM. The role of NOD-like receptors in innate immunity. Front Immunol. 2023;14:1122586. https:\/\/doi.org\/10.3389\/fimmu.2023.1122586.","journal-title":"Front Immunol"},{"key":"1681_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10:128. https:\/\/doi.org\/10.1038\/s41419-019-1413-8.","journal-title":"Cell Death Dis"},{"key":"1681_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fimmu.2018.00104","volume":"9","author":"T Das","year":"2018","unstructured":"Das T, Chen Z, Hendriks RW, Kool M. A20\/tumor necrosis factor \u03b1-induced protein 3 in immune cells controls development of autoinflammation and autoimmunity: lessons from mouse models. Front Immunol. 2018;9:104. https:\/\/doi.org\/10.3389\/fimmu.2018.00104.","journal-title":"Front Immunol"},{"key":"1681_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.immuni.2014.12.031","volume":"42","author":"BH Duong","year":"2015","unstructured":"Duong BH, et al. A20 restricts ubiquitination of pro-interleukin-1\u03b2 protein complexes and suppresses NLRP3 inflammasome activity. Immunity. 2015;42:55\u201367. https:\/\/doi.org\/10.1016\/j.immuni.2014.12.031.","journal-title":"Immunity"},{"key":"1681_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature13322","volume":"512","author":"L VandeWalle","year":"2014","unstructured":"VandeWalle L, et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature. 2014;512:69\u201373.","journal-title":"Nature"},{"key":"1681_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni.3206","volume":"16","author":"J Silke","year":"2015","unstructured":"Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015;16:689\u201397. https:\/\/doi.org\/10.1038\/ni.3206.","journal-title":"Nat Immunol"},{"key":"1681_CR37","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.3172","volume":"16","author":"M Onizawa","year":"2015","unstructured":"Onizawa M, et al. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat Immunol. 2015;16:618\u201327. https:\/\/doi.org\/10.1038\/ni.3172.","journal-title":"Nat Immunol"},{"key":"1681_CR38","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","volume":"289","author":"EG Lee","year":"2000","unstructured":"Lee EG, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000;289:2350\u20134. https:\/\/doi.org\/10.1126\/science.289.5488.2350.","journal-title":"Science"},{"key":"1681_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/s0092-8674(03)00521-x","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181\u201390. https:\/\/doi.org\/10.1016\/s0092-8674(03)00521-x.","journal-title":"Cell"},{"key":"1681_CR40","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/cdd.2017.89","volume":"24","author":"MCC Lim","year":"2017","unstructured":"Lim MCC, et al. Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-\u03baB and caspase-8-dependent apoptotic cell death. Cell Death Differ. 2017;24:1621\u201331. https:\/\/doi.org\/10.1038\/cdd.2017.89.","journal-title":"Cell Death Differ"},{"key":"1681_CR41","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1084\/jem.20180198","volume":"215","author":"MG Kattah","year":"2018","unstructured":"Kattah MG, et al. A20 and ABIN-1 synergistically preserve intestinal epithelial cell survival. J Exp Med. 2018;215:1839\u201352. https:\/\/doi.org\/10.1084\/jem.20180198.","journal-title":"J Exp Med"},{"key":"1681_CR42","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1038\/cdd.2010.47","volume":"17","author":"M Won","year":"2010","unstructured":"Won M, et al. Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. Cell Death Differ. 2010;17:1830\u201341. https:\/\/doi.org\/10.1038\/cdd.2010.47.","journal-title":"Cell Death Differ"},{"key":"1681_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.766","volume":"43","author":"I Adrianto","year":"2011","unstructured":"Adrianto I, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet. 2011;43:253\u20138. https:\/\/doi.org\/10.1038\/ng.766.","journal-title":"Nat Genet"},{"key":"1681_CR44","doi-asserted-by":"publisher","first-page":"1011965","DOI":"10.3389\/fgene.2022.1011965","volume":"13","author":"S Pasula","year":"2022","unstructured":"Pasula S, et al. Systemic lupus erythematosus variants modulate the function of an enhancer upstream of TNFAIP3. Front Genet. 2022;13:1011965. https:\/\/doi.org\/10.3389\/fgene.2022.1011965.","journal-title":"Front Genet"},{"key":"1681_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13075-020-02181-4","volume":"22","author":"T Kim","year":"2020","unstructured":"Kim T, Bae SC, Kang C. Synergistic activation of NF-kappaB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk. Arthritis Res Ther. 2020;22:93. https:\/\/doi.org\/10.1186\/s13075-020-02181-4.","journal-title":"Arthritis Res Ther"},{"key":"1681_CR46","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1002\/art.34490","volume":"64","author":"E Koumakis","year":"2012","unstructured":"Koumakis E, et al. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. Arthritis Rheum. 2012;64:2746\u201352. https:\/\/doi.org\/10.1002\/art.34490.","journal-title":"Arthritis Rheum"},{"key":"1681_CR47","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/annrheumdis-2019-215434","volume":"78","author":"L Odqvist","year":"2019","unstructured":"Odqvist L, et al. Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1363\u201370. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215434.","journal-title":"Ann Rheum Dis"},{"key":"1681_CR48","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/annrheumdis-2015-207731","volume":"75","author":"G Nocturne","year":"2016","unstructured":"Nocturne G, et al. Germline variation of TNFAIP3 in primary Sj\u00f6gren\u2019s syndrome-associated lymphoma. Ann Rheum Dis. 2016;75:780\u20133. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207731.","journal-title":"Ann Rheum Dis"},{"key":"1681_CR49","doi-asserted-by":"publisher","unstructured":"Martens A, van Loo G. A20 at the crossroads of cell death, inflammation, and autoimmunity. Cold Spring Harb Perspect Biol. 2020;12. https:\/\/doi.org\/10.1101\/cshperspect.a036418.","DOI":"10.1101\/cshperspect.a036418"},{"key":"1681_CR50","doi-asserted-by":"publisher","first-page":"104375","DOI":"10.1016\/j.cellimm.2021.104375","volume":"365","author":"I Mont\u00fafar-Robles","year":"2021","unstructured":"Mont\u00fafar-Robles I, et al. Polymorphisms in TNFAIP3, but not in STAT4, BANK1, BLK, and TNFSF4, are associated with susceptibility to Takayasu arteritis. Cell Immunol. 2021;365:104375. https:\/\/doi.org\/10.1016\/j.cellimm.2021.104375.","journal-title":"Cell Immunol"},{"key":"1681_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12967-015-0566-1","volume":"13","author":"L Zhu","year":"2015","unstructured":"Zhu L, et al. Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis. J Transl Med. 2015;13:215. https:\/\/doi.org\/10.1186\/s12967-015-0566-1.","journal-title":"J Transl Med"},{"key":"1681_CR52","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1186\/ar2969","volume":"12","author":"AW Morgan","year":"2010","unstructured":"Morgan AW, et al. Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3\/TNFAIP3, STAT4 and TRAF1\/C5 in an inception cohort. Arthritis Res Ther. 2010;12:R57. https:\/\/doi.org\/10.1186\/ar2969.","journal-title":"Arthritis Res Ther"},{"key":"1681_CR53","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/art.27190","volume":"62","author":"K Shimane","year":"2010","unstructured":"Shimane K, et al. The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthritis Rheum. 2010;62:574\u20139. https:\/\/doi.org\/10.1002\/art.27190.","journal-title":"Arthritis Rheum"},{"key":"1681_CR54","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jdermsci.2020.09.005","volume":"100","author":"M Momose","year":"2020","unstructured":"Momose M, et al. Associations of TNFAIP3 variants with susceptibility to psoriasis vulgaris and psoriasis arthritis in a Japanese population. J Dermatol Sci. 2020;100:220\u20132. https:\/\/doi.org\/10.1016\/j.jdermsci.2020.09.005.","journal-title":"J Dermatol Sci"},{"key":"1681_CR55","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/bjd.15005","volume":"176","author":"J van den Reek","year":"2017","unstructured":"van den Reek J, et al. Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis. Br J Dermatol. 2017;176:1288\u201396. https:\/\/doi.org\/10.1111\/bjd.15005.","journal-title":"Br J Dermatol"},{"key":"1681_CR56","doi-asserted-by":"publisher","first-page":"e0217352","DOI":"10.1371\/journal.pone.0217352","volume":"14","author":"NY Sahlol","year":"2019","unstructured":"Sahlol NY, Mostafa MS, Madkour LAE, Salama DM. Low TNFAIP3 expression in psoriatic skin promotes disease susceptibility and severity. PLoS One. 2019;14:e0217352. https:\/\/doi.org\/10.1371\/journal.pone.0217352.","journal-title":"PLoS One"},{"key":"1681_CR57","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/jid.2011.376","volume":"132","author":"T Tejasvi","year":"2012","unstructured":"Tejasvi T, et al. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. J Invest Dermatol. 2012;132:593\u2013600. https:\/\/doi.org\/10.1038\/jid.2011.376.","journal-title":"J Invest Dermatol"},{"key":"1681_CR58","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1080\/15548627.2018.1458804","volume":"14","author":"Y Zhai","year":"2018","unstructured":"Zhai Y, et al. TNFAIP3-DEPTOR complex regulates inflammasome secretion through autophagy in ankylosing spondylitis monocytes. Autophagy. 2018;14:1629\u201343. https:\/\/doi.org\/10.1080\/15548627.2018.1458804.","journal-title":"Autophagy"},{"key":"1681_CR59","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/ng.874","volume":"43","author":"M Matmati","year":"2011","unstructured":"Matmati M, et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet. 2011;43:908\u201312. https:\/\/doi.org\/10.1038\/ng.874.","journal-title":"Nat Genet"},{"key":"1681_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40779-022-00393-0","volume":"9","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, et al. Novel gene therapy for rheumatoid arthritis with single local injection: adeno-associated virus-mediated delivery of A20\/TNFAIP3. Mil Med Res. 2022;9:34. https:\/\/doi.org\/10.1186\/s40779-022-00393-0.","journal-title":"Mil Med Res"},{"key":"1681_CR61","doi-asserted-by":"publisher","unstructured":"Wolfrum S, Teupser D, Tan M, Chen KY, Breslow JL. The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes. Proc Natl Acad Sci U S A 2007;104:18601-18606.https:\/\/doi.org\/10.1073\/pnas.0709011104.","DOI":"10.1073\/pnas.0709011104"},{"key":"1681_CR62","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/01.Cir.0000083718.76889.D0","volume":"108","author":"CR Longo","year":"2003","unstructured":"Longo CR, et al. A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis. Circulation. 2003;108:1113\u20138. https:\/\/doi.org\/10.1161\/01.Cir.0000083718.76889.D0.","journal-title":"Circulation"},{"key":"1681_CR63","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1126\/science.aac6623","volume":"349","author":"MJ Schuijs","year":"2015","unstructured":"Schuijs MJ, et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science. 2015;349:1106\u201310. https:\/\/doi.org\/10.1126\/science.aac6623.","journal-title":"Science"},{"key":"1681_CR64","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.4049\/jimmunol.0900163","volume":"183","author":"NI Kang","year":"2009","unstructured":"Kang NI, et al. A20 attenuates allergic airway inflammation in mice. J Immunol. 2009;183:1488\u201395. https:\/\/doi.org\/10.4049\/jimmunol.0900163.","journal-title":"J Immunol"},{"key":"1681_CR65","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.jaci.2019.07.029","volume":"144","author":"J Krusche","year":"2019","unstructured":"Krusche J, et al. TNF-alpha-induced protein 3 is a key player in childhood asthma development and environment-mediated protection. J Allergy Clin Immunol. 2019;144:1684-1696 e1612. https:\/\/doi.org\/10.1016\/j.jaci.2019.07.029.","journal-title":"J Allergy Clin Immunol"},{"key":"1681_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.02.026","author":"A Holgado","year":"2023","unstructured":"Holgado A, et al. A20 is a master switch of IL-33 signaling in macrophages and determines IL-33-induced lung immunity. J Allergy Clin Immunol. 2023. https:\/\/doi.org\/10.1016\/j.jaci.2023.02.026.","journal-title":"J Allergy Clin Immunol"},{"key":"1681_CR67","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nature07969","volume":"459","author":"M Kato","year":"2009","unstructured":"Kato M, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature. 2009;459:712\u20136. https:\/\/doi.org\/10.1038\/nature07969.","journal-title":"Nature"},{"key":"1681_CR68","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.20090528","volume":"206","author":"R Schmitz","year":"2009","unstructured":"Schmitz R, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med. 2009;206:981\u20139. https:\/\/doi.org\/10.1084\/jem.20090528.","journal-title":"J Exp Med"},{"key":"1681_CR69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","volume":"11","author":"M Roschewski","year":"2014","unstructured":"Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol. 2014;11:12\u201323. https:\/\/doi.org\/10.1038\/nrclinonc.2013.197.","journal-title":"Nat Rev Clin Oncol"},{"key":"1681_CR70","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1182\/bloodadvances.2022009412","volume":"7","author":"M Tatarczuch","year":"2023","unstructured":"Tatarczuch M, et al. Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma. Blood Adv. 2023;7:3531\u20139. https:\/\/doi.org\/10.1182\/bloodadvances.2022009412.","journal-title":"Blood Adv"},{"key":"1681_CR71","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","volume":"122","author":"G Nocturne","year":"2013","unstructured":"Nocturne G, et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren\u2019s syndrome. Blood. 2013;122:4068\u201376. https:\/\/doi.org\/10.1182\/blood-2013-05-503383.","journal-title":"Blood"},{"key":"1681_CR72","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.immuni.2010.07.017","volume":"33","author":"RM Tavares","year":"2010","unstructured":"Tavares RM, et al. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity. 2010;33:181\u201391. https:\/\/doi.org\/10.1016\/j.immuni.2010.07.017.","journal-title":"Immunity"},{"key":"1681_CR73","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cell.2020.01.029","volume":"180","author":"M Singh","year":"2020","unstructured":"Singh M, et al. Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody. Cell. 2020;180:878-894 e819. https:\/\/doi.org\/10.1016\/j.cell.2020.01.029.","journal-title":"Cell"},{"key":"1681_CR74","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood.2021013164","volume":"139","author":"H Cheon","year":"2022","unstructured":"Cheon H, et al. Genomic landscape of TCRalphabeta and TCRgammadelta T-large granular lymphocyte leukemia. Blood. 2022;139:3058\u201372. https:\/\/doi.org\/10.1182\/blood.2021013164.","journal-title":"Blood"},{"key":"1681_CR75","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1182\/blood.2020005831","volume":"138","author":"TL Olson","year":"2021","unstructured":"Olson TL, et al. Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias. Blood. 2021;138:662\u201373. https:\/\/doi.org\/10.1182\/blood.2020005831.","journal-title":"Blood"},{"key":"1681_CR76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2021.04.017","volume":"511","author":"Y Shi","year":"2021","unstructured":"Shi Y, et al. The dual roles of A20 in cancer. Cancer Lett. 2021;511:26\u201335. https:\/\/doi.org\/10.1016\/j.canlet.2021.04.017.","journal-title":"Cancer Lett"},{"key":"1681_CR77","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","volume":"77","author":"FA Aeschlimann","year":"2018","unstructured":"Aeschlimann FA, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018;77:728\u201335. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212403.","journal-title":"Ann Rheum Dis"},{"key":"1681_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.12.007","author":"I Elhani","year":"2023","unstructured":"Elhani I, et al. A20 haploinsufficiency: a systematic review of 177 cases. J Invest Dermatol. 2023. https:\/\/doi.org\/10.1016\/j.jid.2023.12.007.","journal-title":"J Invest Dermatol"},{"key":"1681_CR79","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-021-02434-w","volume":"23","author":"S Kadowaki","year":"2021","unstructured":"Kadowaki S, et al. Functional analysis of novel A20 variants in patients with atypical inflammatory diseases. Arthritis Res Ther. 2021;23:52. https:\/\/doi.org\/10.1186\/s13075-021-02434-w.","journal-title":"Arthritis Res Ther"},{"key":"1681_CR80","doi-asserted-by":"publisher","first-page":"108441","DOI":"10.1016\/j.clim.2020.108441","volume":"216","author":"T Kadowaki","year":"2020","unstructured":"Kadowaki T, et al. Immunophenotyping of A20 haploinsufficiency by multicolor flow cytometry. Clin Immunol. 2020;216:108441. https:\/\/doi.org\/10.1016\/j.clim.2020.108441.","journal-title":"Clin Immunol"},{"key":"1681_CR81","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12519-019-00288-6","volume":"16","author":"MP Yu","year":"2020","unstructured":"Yu MP, Xu XS, Zhou Q, Deuitch N, Lu MP. Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment. World J Pediatr. 2020;16:575\u201384. https:\/\/doi.org\/10.1007\/s12519-019-00288-6.","journal-title":"World J Pediatr"},{"key":"1681_CR82","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead628","author":"A Burleigh","year":"2023","unstructured":"Burleigh A, et al. Genetic testing of Behcet\u2019s disease using next-generation sequencing to identify monogenic mimics and HLA-B*51. Rheumatology (Oxford). 2023. https:\/\/doi.org\/10.1093\/rheumatology\/kead628.","journal-title":"Rheumatology (Oxford)"},{"key":"1681_CR83","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12969-022-00735-1","volume":"20","author":"N Aslani","year":"2022","unstructured":"Aslani N, et al. TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases. Pediatr Rheumatol Online J. 2022;20:78. https:\/\/doi.org\/10.1186\/s12969-022-00735-1.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1681_CR84","doi-asserted-by":"publisher","first-page":"780689","DOI":"10.3389\/fimmu.2021.780689","volume":"12","author":"T Kadowaki","year":"2021","unstructured":"Kadowaki T, Kadowaki S, Ohnishi H. A20 Haploinsufficiency in East Asia. Front Immunol. 2021;12:780689. https:\/\/doi.org\/10.3389\/fimmu.2021.780689.","journal-title":"Front Immunol"},{"key":"1681_CR85","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/annrheumdis-2019-215918","volume":"79","author":"DM Schwartz","year":"2020","unstructured":"Schwartz DM, et al. Type I interferon signature predicts response to JAK inhibition in haploinsufficiency of A20. Ann Rheum Dis. 2020;79:429\u201331. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215918.","journal-title":"Ann Rheum Dis"},{"key":"1681_CR86","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/ckj\/sfac130","volume":"15","author":"C Zhang","year":"2022","unstructured":"Zhang C, et al. Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis. Clin Kidney J. 2022;15:2027\u201338. https:\/\/doi.org\/10.1093\/ckj\/sfac130.","journal-title":"Clin Kidney J"},{"key":"1681_CR87","doi-asserted-by":"publisher","first-page":"574992","DOI":"10.3389\/fimmu.2020.574992","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, et al. Association of clinical phenotypes in haploinsufficiency A20 (HA20) with disrupted domains of A20. Front Immunol. 2020;11:574992. https:\/\/doi.org\/10.3389\/fimmu.2020.574992.","journal-title":"Front Immunol"},{"key":"1681_CR88","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.14003","author":"T Iwasa","year":"2023","unstructured":"Iwasa T, et al. A case of A20 haploinsufficiency complicated by autoimmune hepatitis. Hepatol Res. 2023. https:\/\/doi.org\/10.1111\/hepr.14003.","journal-title":"Hepatol Res"},{"key":"1681_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.09.028","author":"S Pandurangi","year":"2023","unstructured":"Pandurangi S, et al. Deleterious variants in TNFAIP3 are associated with type II and seronegative pediatric autoimmune hepatitis. J Hepatol. 2023. https:\/\/doi.org\/10.1016\/j.jhep.2023.09.028.","journal-title":"J Hepatol"},{"key":"1681_CR90","unstructured":"Harasimowicz M, Stone D, Carpio Tumba M, Romeo T, Karri U, Hoffmann P, et al. Liver disease is a common feature of HA20 that causes significant morbidity associated with interferon induction [abstract]. Arthritis Rheumatol. 2023;75(suppl 9). https:\/\/acrabstracts.org\/abstract\/liver-disease-is-a-common-feature-of-ha20-that-causes-significant-morbidity-associated-with-interferon-induction\/. Accessed 2 Mar 2024."},{"key":"1681_CR91","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3389\/fimmu.2019.03022","volume":"10","author":"M Christiansen","year":"2019","unstructured":"Christiansen M, et al. Identification of novel genetic variants in CVID patients with autoimmunity, autoinflammation, or malignancy. Front Immunol. 2019;10:3022. https:\/\/doi.org\/10.3389\/fimmu.2019.03022.","journal-title":"Front Immunol"},{"key":"1681_CR92","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.jaci.2016.09.038","volume":"139","author":"M Takagi","year":"2017","unstructured":"Takagi M, et al. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol. 2017;139:1914\u201322. https:\/\/doi.org\/10.1016\/j.jaci.2016.09.038.","journal-title":"J Allergy Clin Immunol"},{"key":"1681_CR93","doi-asserted-by":"publisher","unstructured":"Schwartz DM, et al. Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features. Ann Rheum Dis. 2021;annrheumdis-2020\u2013219137. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219137.","DOI":"10.1136\/annrheumdis-2020-219137"},{"key":"1681_CR94","doi-asserted-by":"publisher","first-page":"1756.1751","DOI":"10.1136\/annrheumdis-2022-eular.3269","volume":"81","author":"S Amikishiyev","year":"2022","unstructured":"Amikishiyev S, et al. Differences in the clinical spectrum of haploinsufficiency of A20 (Ha20) cases diagnosed during adulthood. Ann Rheum Dis. 2022;81:1756.1751-1756. https:\/\/doi.org\/10.1136\/annrheumdis-2022-eular.3269.","journal-title":"Ann Rheum Dis"},{"key":"1681_CR95","doi-asserted-by":"publisher","first-page":"804401","DOI":"10.3389\/fimmu.2022.804401","volume":"13","author":"MN Rossi","year":"2022","unstructured":"Rossi MN, et al. Identification of a novel mutation in TNFAIP3 in a family with poly-autoimmunity. Front Immunol. 2022;13:804401. https:\/\/doi.org\/10.3389\/fimmu.2022.804401.","journal-title":"Front Immunol"},{"key":"1681_CR96","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.immuni.2020.07.006","volume":"53","author":"CN Gruber","year":"2020","unstructured":"Gruber CN, et al. Complex autoinflammatory syndrome unveils fundamental principles of JAK1 kinase transcriptional and biochemical function. Immunity. 2020;53:672-684 e611. https:\/\/doi.org\/10.1016\/j.immuni.2020.07.006.","journal-title":"Immunity"},{"key":"1681_CR97","doi-asserted-by":"publisher","unstructured":"Stewart OJ, Patel R, Gruber C, Bogunovic D. Resolving incomplete penetrance in primary immunodeficiencies. Clin Immunol. 2023;250. https:\/\/doi.org\/10.1016\/j.clim.2023.109357.","DOI":"10.1016\/j.clim.2023.109357"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01681-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01681-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01681-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T07:19:07Z","timestamp":1713856747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01681-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1681"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01681-1","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"26 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DMS is a consultant for Sobi Pharmaceuticals and receives research funding from Eli Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"76"}}